254 related articles for article (PubMed ID: 29690575)
1. Natural Immunity to HIV: A Template for Vaccine Strategies.
Fourcade L; Poudrier J; Roger M
Viruses; 2018 Apr; 10(4):. PubMed ID: 29690575
[TBL] [Abstract][Full Text] [Related]
2. Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequencies of innate marginal zone like CD1c+ B-cells in the genital tract.
Fourcade L; Sabourin-Poirier C; Perraud V; Faucher MC; Chagnon-Choquet J; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
PLoS Pathog; 2019 Jun; 15(6):e1007840. PubMed ID: 31173604
[TBL] [Abstract][Full Text] [Related]
3. Blood B Lymphocyte Stimulator (BLyS)/BAFF levels may reflect natural immunity to HIV in highly exposed uninfected Beninese Commercial Sex Workers.
Sabourin-Poirier C; Fourcade L; Chagnon-Choquet J; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
Sci Rep; 2016 Aug; 6():32318. PubMed ID: 27561453
[TBL] [Abstract][Full Text] [Related]
4. Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers.
Batraville LA; Richard J; Veillette M; Labbé AC; Alary M; Guédou F; Kaufmann DE; Poudrier J; Finzi A; Roger M
AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1145-9. PubMed ID: 25354025
[TBL] [Abstract][Full Text] [Related]
5. Highly-Exposed HIV-1 seronegative Female Commercial Sex Workers sustain in their genital mucosa increased frequencies of tolerogenic myeloid and regulatory T-cells.
Thibodeau V; Fourcade L; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
Sci Rep; 2017 Mar; 7():43857. PubMed ID: 28262752
[TBL] [Abstract][Full Text] [Related]
6. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers.
Iqbal SM; Ball TB; Kimani J; Kiama P; Thottingal P; Embree JE; Fowke KR; Plummer FA
J Infect Dis; 2005 Sep; 192(5):728-38. PubMed ID: 16088822
[TBL] [Abstract][Full Text] [Related]
7. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2017 May; 91(9):. PubMed ID: 28179536
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
Munusamy Ponnan S; Thiruvengadam K; Tellapragada C; Ambikan AT; Narayanan A; Kathirvel S; Mathayan M; Shankar J; Rajaraman A; Afshan Amanulla M; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Velu V; Shacklett B; Neogi U; Hanna LE
Microbiol Spectr; 2021 Oct; 9(2):e0047021. PubMed ID: 34704803
[TBL] [Abstract][Full Text] [Related]
9. Immunologic profiles of HIV-infected and uninfected commercial sex workers in the Vellore region of Southern India.
Babu PG; Pramilabai A; Sripriya G; Damodharan S; John TJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(5):357-61. PubMed ID: 9420314
[TBL] [Abstract][Full Text] [Related]
10. Monocyte Gene and Molecular Expression Profiles Suggest Distinct Effector and Regulatory Functions in Beninese HIV Highly Exposed Seronegative Female Commercial Sex Workers.
Blondin-Ladrie L; Fourcade L; Modica A; Aranguren M; de Montigny N; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215954
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.
Ruiz MJ; Salido J; Abusamra L; Ghiglione Y; Cevallos C; Damilano G; Rodriguez AM; Trifone C; Laufer N; Giavedoni LD; Sued O; Salomón H; Gherardi MM; Turk G
EBioMedicine; 2017 Dec; 26():25-37. PubMed ID: 29129698
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
Akapirat S; Karnasuta C; Vasan S; Rerks-Ngarm S; Pitisuttithum P; Madnote S; Savadsuk H; Rittiroongrad S; Puangkaew J; Phogat S; Tartaglia J; Sinangil F; de Souza MS; Excler JL; Kim JH; Robb ML; Michael NL; Ngauy V; O'Connell RJ; Karasavvas N;
PLoS One; 2018; 13(4):e0196397. PubMed ID: 29702672
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract.
Hervouet C; Luci C; Cuburu N; Cremel M; Bekri S; Vimeux L; Marañon C; Czerkinsky C; Hosmalin A; Anjuère F
Vaccine; 2010 Aug; 28(34):5582-90. PubMed ID: 20600505
[TBL] [Abstract][Full Text] [Related]
14. The Importance of Regulation in Natural Immunity to HIV.
Blondin-Ladrie L; Aranguren M; Doyon-Laliberté K; Poudrier J; Roger M
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33803543
[TBL] [Abstract][Full Text] [Related]
15. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
16. Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions.
Doyon-Laliberté K; Aranguren M; Poudrier J; Roger M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328792
[TBL] [Abstract][Full Text] [Related]
17. A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.
Agwale SM; Shata MT; Reitz MS; Kalyanaraman VS; Gallo RC; Popovic M; Hone DM
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10037-41. PubMed ID: 12096189
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 vaccines: challenges and new perspectives.
Excler JL; Robb ML; Kim JH
Hum Vaccin Immunother; 2014; 10(6):1734-46. PubMed ID: 24637946
[TBL] [Abstract][Full Text] [Related]
19. A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen.
Vijayan A; García-Arriaza J; Raman SC; Conesa JJ; Chichón FJ; Santiago C; Sorzano CÓ; Carrascosa JL; Esteban M
PLoS One; 2015; 10(7):e0133595. PubMed ID: 26208356
[TBL] [Abstract][Full Text] [Related]
20. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
